[Cogan-I syndrome: interstitial keratitis with sudden deafness].
D000287:Administration, Topical; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D003638:Deafness / Q000150:complications*; D006801:Humans; D007634:Keratitis / Q000150:complications* / Q000188:drug therapy; D007759:Labyrinth Diseases / Q000150:complications*; D008297:Male; D011239:Prednisolone; D012737:Sex Factors; D013577:Syndrome; D014012:Tinnitus / Q000150:complications; D014717:Vertigo / Q000150:complications; D014722:Vestibule, Labyrinth / Q000503:physiopathology; D014786:Vision Disorders / Q000150:complications
D000893:Anti-Inflammatory Agents; D011239:Prednisolone